Mark Berger
2019
In 2019, Mark Berger earned a total compensation of $554.4K as Chief Medical Officer at Actinium Pharmaceuticals, a 9% decrease compared to previous year.
Compensation breakdown
Bonus | $85,000 |
---|---|
Option Awards | $64,364 |
Salary | $405,000 |
Total | $554,364 |
Berger received $405K in salary, accounting for 73% of the total pay in 2019.
Berger also received $85K in bonus and $64.4K in option awards.
Rankings
In 2019, Mark Berger's compensation ranked 11,442nd out of 13,971 executives tracked by ExecPay. In other words, Berger earned more than 18.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,442 out of 13,971 | 18th |
Division Manufacturing | 4,635 out of 5,701 | 19th |
Major group Chemicals And Allied Products | 1,827 out of 2,200 | 17th |
Industry group Drugs | 1,573 out of 1,886 | 17th |
Industry Pharmaceutical Preparations | 1,163 out of 1,398 | 17th |
Source: SEC filing on October 7, 2020.
Berger's colleagues
We found three more compensation records of executives who worked with Mark Berger at Actinium Pharmaceuticals in 2019.